VTRS Viatris

$16.94 -0.88%

Updated 16 d ago

Healthcare · Pharmaceutical Preparations

Viatris (VTRS) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $19.5 billion. Shares last traded at $16.94, 7.7% below their 52-week high. Over the past year the stock is up 60.5%. Net profit margin is -23.9%, below the peer median of -8.9%. Revenue declined 3.0% year over year. The shares yield 2.8% in dividends.

Market Cap

$19.5B

Shares Out

1.15B

EPS (TTM)

$-5.08

P/E Ratio

—

P/S Ratio

1.32

P/B Ratio

1.36

Dividend / Share

$0.48

Dividend Yield

2.83%

52-Week High

$18.34

52-Week Low

$9.43

Volume

380,245

Avg Vol (3m)

687,528.254

Performance

+0.30%

-3.94%

+6.51%

+16.55%

YTD

+35.85%

+60.49%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

55.11

SMA (50)

$16.75

SMA (200)

$14.69

Price vs SMA50

+1.13%

Price vs SMA200

+15.31%

ATR (14)

$0.45

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$14.7B

Net Income

$-3515M

Gross Margin

34.9%

Operating Margin

-0.6%

Net Margin

-23.9%

Return on Equity

-24.6%

Return on Assets

-10.0%

Current Ratio

1.58

Debt / Equity

0.81

Revenue Growth (YoY)

-3.0%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$0.05	2026-08-06
Q1 2026	$0.15	2026-05-07
FY 2025	$-3.00	2026-02-26
Q3 2025	$-2.70	2025-11-06
Q2 2026	$-2.58	2026-08-06
Q1 2026	$-2.55	2026-05-07

Full earnings history →

Pharmaceutical Preparations peers

VTRS vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 16 d ago

P/S vs peers

1.32 / 11.11 med

-88% discount

Net margin vs peers

-23.9% / -8.9% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.